insights_auto
Why is TNXP down 2,26%?
Dive Deeperchevron_right
TNXP:NASDAQ
Tonix Pharmaceuticals Holding Corp
6,49 $
arrow_downward
-2,26%(-0,15) 1D
13 հոկ, 11:26:47 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TNXP...
Open
6,61 $
High
6,68 $
Low
6,30 $
Mkt. cap
111,31 մլն
Avg. vol.
610,54 հզր
Volume
501,41 հզր
52-wk high
20,69 $
52-wk low
6,30 $
EPS
-12,92 $
Beta
1,78
Shares outstanding
17,15 մլն
No. of employees
142
Open
6,61 $
High
6,68 $
Low
6,30 $
Mkt. cap
111,31 մլն
Avg. vol.
610,54 հզր
Volume
501,41 հզր
52-wk high
20,69 $
52-wk low
6,30 $
EPS
-12,92 $
Beta
1,78
Shares outstanding
17,15 մլն
No. of employees
142
News stories
From web sources and news partners
Benzinga
·
40 րոպե առաջ
VERAXA Biotech (NASDAQ: VRXA) Presents First In Vivo Proof-of-Concept Data for BiTAC-ADC Platform at Worl
Dealroom
·
22 րոպե առաջ
CDT Equity taps J.J. Astor for $6.75M convertible note
Investing News Network
·
9 րոպե առաջ
NYSE Touches Down at TechCrunch Disrupt: NYSE Content Update
Profile
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project. Wikipedia
About Tonix Pharmaceuticals Holding Corp
CEOSeth Lederman
Employees142
Founded2007
HeadquartersԲերքլի Հեյթս, Նյու Ջերսի, Միացյալ Նահանգներ
Sector-
Websitetonixpharma.com